Citation Impact

Citing Papers

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
High levels of untreated distress and fatigue in cancer patients
2004 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Health-Related Quality-of-Life Assessments and Patient-Physician Communication
2002
Targeting hypoxia in cancer therapy
2011 Standout
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma
2004
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
2007
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Head and neck cancer
2008 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
2011
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Primary CNS Lymphoma: Treatment with Combined Chemotherapy and Radiotherapy
1999
Early FDG-PET imaging after radical radiotherapy for non–small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation
2004
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
2003
Malignant Gliomas in Adults
2008 Standout
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
2013
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer
2006
Primary brain tumours in adults
2012 Standout
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
2004
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
2006
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma
2001
PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes
2007
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Overview of early response assessment in lymphoma with FDG-PET
2007
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma
2003
Health outcomes of bereavement
2007 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
A semiautomatic CT-based ensemble segmentation of lung tumors: Comparison with oncologists’ delineations and with the surgical specimen
2012
Brain Tumors
2001 Standout
The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis
2007
A heuristic approach for single-machine scheduling with due dates and class setups
2001
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
States and belief states
1995
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
A follow-up survey of berth allocation and quay crane scheduling problems in container terminals
2014 Standout
A method for eliciting and comparing causal maps
1995
Making knowledge the basis of a dynamic theory of the firm
1996 Standout
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
2014
[18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer
2005
Understanding Radical Organizational Change: Bringing Together the Old and the New Institutionalism
1996 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Scheduling with batching: A review
2000
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
2001
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials
2014
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
2001
Psychological Safety and Learning Behavior in Work Teams
1999 Standout
Parallel machine scheduling by family batching with sequence-independent set-up times
2006
Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
2003
Goal constructs in psychology: Structure, process, and content.
1996 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
ADOPTION OF AN ORGANIZATIONAL PRACTICE BY SUBSIDIARIES OF MULTINATIONAL CORPORATIONS: INSTITUTIONAL AND RELATIONAL EFFECTS.
2002 Standout
Heuristic procedures for scheduling job families with setups and due dates
1999
Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer
2003
PET-based treatment planning in radiotherapy: a new standard?
2007
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Psychosocial morbidity associated with patterns of family functioning in palliative care: baseline data from the Family Focused Grief Therapy controlled trial
2003
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Minimizing sum of completion times on a single machine with sequence-dependent family setup times
2005
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma
2000
Review of Electronic Patient-Reported Outcomes Systems Used in Cancer Clinical Care
2014
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial
2004
Managerial and Organizational Cognition: Notes from a Trip Down Memory Lane
1995 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
A review of scheduling research involving setup considerations
1999
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Seaside operations in container terminals: literature overview, trends, and research directions
2013
A survey of scheduling problems with setup times or costs
2006 Standout
Social Capital, Intellectual Capital, and the Organizational Advantage
1998 Standout

Works of Andrew Wirth being referenced

Primary central nervous system lymphoma: age and performance status are more important than treatment modality
1998
Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma
2005
Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancer
2001
Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center
2002
Measurement of lung tumor volumes using three-dimensional computer planning software
2002
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)
2006
Imaging with F‐18 FDG PET is superior to Tl‐201 SPECT in the staging of non‐small cell lung cancer for radical radiation therapy*
2001
Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
2005
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline
2012
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy
2005
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma
2001
Early therapeutic response assessment by18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
2007
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
2002
FDG-PET-Detected Extracranial Metastasis in Patients with Non-Small Cell Lung Cancer Undergoing Staging for Surgery or Radical Radiotherapy
2003
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
2001
Scheduling parallel machines with a single server: some solvable cases and heuristics
2002
A comparison of branch-and-bound algorithms for a family scheduling problem with identical parallel machines
2004
A New Heuristic for a Single Machine Scheduling Problem with Set-up Times
1996
Measuring Differences Between Cognitive Maps
1992
Lower bounds and algorithms for flowtime minimization on a single machine with set-up times
2000
On-line scheduling with non-crossing constraints
2008
Randomized Trial of Coordinated Psychosocial Interventions Based on Patient Self-Assessments Versus Standard Care to Improve the Psychosocial Functioning of Patients With Cancer
2001
Frequent Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography on the Staging and Management of Patients with Indolent Non-Hodgkin's Lymphoma
2003
Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma
2008
Scheduling two parallel machines with a single server: the general case
2004
Equal processing and equal setup time cases of scheduling parallel machines with a single server
2003
Earliness/tardiness scheduling with a common due date and family setups
2004
Heuristic methods for the identical parallel machine flowtime problem with set-up times
2004
Rankless by CCL
2026